A randomized, double-blind, placebo-controlled study of losmapimod in patients with facioscapulohumeral muscular dystrophy: Results of the REACH study. [PDF]
Voermans NC +30 more
europepmc +1 more source
Hearing Loss, Retinal Abnormality, and Seizures in People With Facioscapulohumeral Muscular Dystrophy. [PDF]
Kilburn SN +8 more
europepmc +1 more source
Study of Testosterone and Recombinant Human Growth Hormone in Facioscapulohumeral Muscular Dystrophy. [PDF]
Heatwole CR +20 more
europepmc +1 more source
Facioscapulohumeral muscular dystrophy.
Jana, Pospisilova +2 more
openaire +1 more source
Response to: Disentangling Facioscapulohumeral Muscular Dystrophy Disability From Age and Comorbidities: A Call for Refined Stratification. [PDF]
Teeselink S, Mul K.
europepmc +1 more source
Association of Diaphragm Involvement Assessed by Ultrasound With Disease Severity in Facioscapulohumeral Muscular Dystrophy. [PDF]
Xu X +18 more
europepmc +1 more source
Visual Diagnosis of Facioscapulohumeral Muscular Dystrophy (FSHD). [PDF]
Erdmann H, Abicht A, Becker K.
europepmc +1 more source
Rethinking genomics of facioscapulohumeral muscular dystrophy in the telomere-to-telomere era: pitfalls in the hidden landscape of D4Z4 repeats. [PDF]
Salsi V +4 more
europepmc +1 more source
Predictive value of D4Z4 methylation levels for phenotypic heterogeneity and disease progression in Facioscapulohumeral Muscular Dystrophy with borderline D4Z4 repeat units: a retrospective cohort study. [PDF]
Lin X +7 more
europepmc +1 more source
The recent clinical trial of losmapimod for the treatment of facioscapulohumeral muscular dystrophy. [PDF]
Bloch RJ +3 more
europepmc +1 more source

